Luminex Corp. Company Profile (NASDAQ:LMNX)

About Luminex Corp.

Luminex Corporation develops, manufactures and sells biological testing technologies with applications throughout the diagnostics, pharmaceutical and life sciences industries. The Company has a range of instruments using its xMAP technology, including its LUMINEX 100/200 systems offer 100-plex testing; the Company's FLEXMAP 3D system is its high-throughput, 500-plex testing system, and its MAGPIX system provides 50-plex testing using imaging rather than flow cytometry. By using its xMAP technology, the end users are able to generate multiple simultaneous results per sample. The Company primarily serves the diagnostics, pharmaceutical and life sciences industries by marketing products, including its testing equipment and assays, to various types of testing laboratories. The Company's assay products are focused on three segments of the molecular diagnostic testing market: human genetics, personalized medicine and infectious disease.

Industry, Sector and Symbol:

• Sector: Medical
• Industry: Medical Instruments & Supplies
• Sub-Industry: Life Sciences Tools & Services
• Exchange: NASDAQ
• Symbol: LMNX
• CUSIP: 55027E10

Key Metrics:

• Previous Close: $22.55
• 50 Day Moving Average: $21.68
• 200 Day Moving Average: $20.71
• 52-Week Range: $16.16 - $23.75
• Trailing P/E Ratio: 23.54
• Foreward P/E Ratio: 35.79
• P/E Growth: 0.64
• Market Cap: $982.01M
• Outstanding Shares: 43,548,000
• Beta: 0.45

Profitability:

• Net Margins: 16.60%
• Return on Equity: 13.65%
• Return on Assets: 12.52%

Debt:

• Current Ratio: 4.79%
• Quick Ratio: 3.54%

Additional Links:

• Visit Luminex Corp.'s Official Website
• View LMNX on Google Finance
• View LMNX on Yahoo Finance
• View LMNX's Company Profile on Reuters
• Search for Luminex Corp. on Google

Companies Related to Luminex Corp.:

• Ophthotech Corp. (NASDAQ:OPHT)
• Surgical Care Affiliates (NASDAQ:SCAI)
• Lexicon Pharmaceuticals (NASDAQ:LXRX)
• HMS Holdings Corp. (NASDAQ:HMSY)
• Haemonetics Corp. (NYSE:HAE)
• Spark Therapeutics (NASDAQ:ONCE)
• The Advisory Board (NASDAQ:ABCO)
• Exact Sciences Corp. (NASDAQ:EXAS)
• Select Medical Holdings Corp. (NYSE:SEM)
• Impax Laboratories (NASDAQ:IPXL)

Earnings

Earnings History for Luminex Corp. (NASDAQ:LMNX)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call	Details
10/31/2016
7/28/2016	Q216	$0.15	$0.33	$61.20 million	$64.20 million	View	Listen
5/2/2016	Q116	$0.14	$0.29	$60.98 million	$63.00 million	View	Listen
2/1/2016	Q415	$0.15	$0.56	$60.16 million	$60.40 million	View	N/A
11/2/2015	Q315	$0.11	$0.22	$57.24 million	$60.60 million	View	Listen
8/3/2015	Q215	$0.11	$0.27	$57.01 million	$58.90 million	View	Listen
5/4/2015	Q115	$0.12	$0.23	$56.50 million	$57.70 million	View	Listen
2/2/2015	Q414	$0.12	$0.19	$58.31 million	$58.10 million	View	Listen
10/27/2014	Q314	$0.10	$0.27	$56.60 million	$56.68 million	View	Listen
7/28/2014	Q214	$0.10	$0.20	$55.90 million	$55.50 million	View	Listen
4/28/2014	Q114	$0.12	$0.24	$55.31 million	$56.60 million	View	Listen
2/3/2014	Q413	$0.07	$0.21	$56.63 million	$55.20 million	View	Listen
11/4/2013	Q313	$0.11	$0.02	$54.67 million	$50.80 million	View	Listen
7/29/2013	Q2 2013	$0.10	$0.17	$54.16 million	$54.30 million	View	Listen
4/29/2013	Q1 2013	$0.08	$0.19	$51.94 million	$53.20 million	View	Listen
2/4/2013	Q4 2012	$0.08	$0.12	$54.09 million	$55.53 million	View	Listen
10/29/2012	Q312	$0.06	$0.04	$51.26 million	$50.00 million	View	N/A
7/30/2012		$0.08	$0.07			View	N/A
4/30/2012		$0.09	$0.08			View	N/A
2/6/2012		$0.07	$0.11			View	N/A
11/1/2011		$0.05	$0.05			View	N/A
8/8/2011		$0.06	$0.11			View	N/A
5/9/2011		$0.06	$0.11			View	N/A
2/7/2011		$0.05	$0.07			View	N/A

(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Luminex Corp. (NASDAQ:LMNX)

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2016	2	$0.13	$0.14	$0.14
Q2 2016	3	$0.14	$0.19	$0.17
Q3 2016	3	$0.04	$0.19	$0.12
Q4 2016	3	$0.05	$0.18	$0.13
Q1 2017	1	$0.06	$0.06	$0.06
Q2 2017	1	$0.09	$0.09	$0.09
Q3 2017	1	$0.07	$0.07	$0.07
Q4 2017	1	$0.10	$0.10	$0.10

(Data provided by Zacks Investment Research)

Dividends

Dividend History for Luminex Corp. (NASDAQ:LMNX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Luminex Corp. (NASDAQ:LMNX)

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Details
1/4/2016	G Walter Loewenbaum II	Director	Sell	41,056	$20.53	$842,879.68
12/31/2015	G Walter Loewenbaum II	Director	Sell	18,944	$21.65	$410,137.60
12/16/2015	Russell W. Bradley	CMO	Sell	6,514	$22.75	$148,193.50
5/28/2015	Nachum Shamir	CEO	Buy	6,000	$16.73	$100,380.00
5/27/2015	G Walter Loewenbaum II	Director	Buy	38,966	$16.71	$651,121.86
2/5/2015	Fred C Goad Jr	Director	Sell	25,000	$15.46	$386,500.00
10/8/2014	Russell W Bradley	SVP	Sell	5,000	$20.50	$102,500.00
5/15/2014	Patrick Balthrop	CEO	Sell	70,000	$17.69	$1,238,300.00
5/12/2014	Kevin Mcnamara	Director	Sell	5,000	$17.95	$89,750.00
5/9/2014	Jim Kever	Director	Sell	5,000	$17.52	$87,600.00
5/7/2014	Patrick Balthrop	CEO	Sell	32,575	$17.63	$574,297.25
5/6/2014	Patrick Balthrop	CEO	Sell	60,000	$18.28	$1,096,800.00
5/2/2014	Fred Goad, Jr.	Director	Sell	50,000	$18.86	$943,000.00
5/2/2014	Patrick Balthrop	CEO	Sell	55,000	$19.05	$1,047,750.00
5/1/2014	David Reiter	SVP	Sell	15,000	$19.09	$286,350.00
5/1/2014	Harriss Currie	CFO	Sell	11,000	$19.08	$209,880.00
9/23/2013	Harriss Currie	CFO	Sell	30,000	$19.88	$596,400.00
9/17/2013	Harriss Currie	CFO	Sell	30,000	$19.87	$596,100.00
9/13/2013	Michael Pintek	SVP	Sell	3,000	$20.00	$60,000.00
8/30/2013	G Walter Loewenbaum II	Director	Buy	6,034	$20.62	$124,421.08
8/28/2013	G Walter Loewenbaum II	Director	Buy	20,000	$20.76	$415,200.00
8/16/2013	Timothy Dehne	VP	Sell	32,297	$20.66	$667,256.02
8/15/2013	G Walter Loewenbaum II	Director	Buy	10,000	$20.82	$208,200.00
8/14/2013	Timothy Dehne	VP	Sell	1,793	$21.21	$38,029.53
8/9/2013	G Walter Loewenbaum II	Director	Buy	4,600	$21.17	$97,382.00
8/2/2013	G Walter Loewenbaum II	Director	Buy	27,000	$20.01	$540,270.00
8/2/2013	Patrick J Balthrop	CEO	Sell	68,048	$20.01	$1,361,640.48
8/1/2013	David S Reiter	SVP	Sell	15,000	$20.00	$300,000.00
8/1/2013	Thomas W Erickson	Director	Sell	20,000	$20.00	$400,000.00
5/24/2013	Fred C Goad Jr	Director	Buy	11,250	$18.25	$205,312.50
5/17/2013	G Walter Loewenbaum II	Director	Buy	13,000	$18.37	$238,810.00
5/16/2013	Fred C Goad Jr	Director	Buy	8,000	$18.18	$145,440.00
5/15/2013	G Walter Loewenbaum II	Director	Buy	39,500	$18.32	$723,640.00
5/10/2013	David S Reiter	SVP	Sell	10,000	$18.26	$182,600.00
5/10/2013	G Walter Loewenbaum II	Director	Buy	19,000	$18.13	$344,470.00
5/9/2013	G Walter Loewenbaum II	Director	Buy	28,300	$17.21	$487,043.00
5/7/2013	G Walter Loewenbaum II	Director	Buy	64,935	$17.17	$1,114,933.95
5/3/2013	G Walter Loewenbaum II	Director	Buy	24,765	$17.02	$421,500.30
9/4/2012	David S Reiter	VP	Sell	10,000	$20.00	$200,000.00

(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Luminex Corp. (NASDAQ:LMNX)

Date	Headline
	Luminex Corp. – Value Analysis (NASDAQ:LMNX) : September 19, 2016 (NASDAQ:LMNX) www.capitalcube.com - September 19 at 5:56 PM
	Luminex Corp. breached its 50 day moving average in a Bullish Manner : LMNX-US : September 16, 2016 (NASDAQ:LMNX) www.capitalcube.com - September 16 at 11:19 AM
	LUMINEX CORP Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:LMNX) biz.yahoo.com - September 9 at 10:42 AM
	Luminex Poised on Pipeline Strength, System Sales Upbeat (NASDAQ:LMNX) finance.yahoo.com - August 30 at 9:15 AM
	ETF’s with exposure to Luminex Corp. : August 26, 2016 (NASDAQ:LMNX) www.capitalcube.com - August 26 at 5:46 PM
	LUMINEX CORP Files SEC form 8-K/A, Financial Statements and Exhibits (NASDAQ:LMNX) biz.yahoo.com - August 25 at 5:57 PM
	Luminex Corp. breached its 50 day moving average in a Bearish Manner : LMNX-US : August 25, 2016 (NASDAQ:LMNX) www.capitalcube.com - August 25 at 11:01 AM
	Luminex upgraded by JP Morgan (NASDAQ:LMNX) finance.yahoo.com - August 18 at 6:00 PM
	Luminex (LMNX) Receives FDA Clearance for xMAP Assay (NASDAQ:LMNX) finance.yahoo.com - August 15 at 6:09 PM
	ETF’s with exposure to Luminex Corp. : August 15, 2016 (NASDAQ:LMNX) www.capitalcube.com - August 15 at 6:09 PM
	Luminex Corp. :LMNX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 (NASDAQ:LMNX) www.capitalcube.com - August 12 at 6:03 PM
	Are You Watching Medpace's IPO? Don't Ignore Its Larger Rival (NASDAQ:LMNX) www.investors.com - August 12 at 6:03 PM
	AUSTIN: Biotech firm joins fight against Zika (NASDAQ:LMNX) www.bizjournals.com - August 11 at 6:18 PM
	Biotech firm joins fight against Zika (NASDAQ:LMNX) www.bizjournals.com - August 10 at 8:56 AM
	Luminex : Receives FDA Clearance for New Molecular Test for Identification and Differentiation of Influenza A/B and Respiratory Syncytial Virus (NASDAQ:LMNX) www.4-traders.com - August 9 at 9:00 AM
	Luminex gets FDA emergency approval for Zika test (NASDAQ:LMNX) gsnmagazine.com - August 9 at 9:00 AM
	Luminex Corporation Receives FDA Emergency Use Authorization for Zika Virus Molecular Detection Assay (NASDAQ:LMNX) www.prnewswire.com - August 9 at 9:00 AM
	Luminex Corp. (LMNX) Receives FDA EUA for Zika Virus Molecular Detection Assay (NASDAQ:LMNX) www.streetinsider.com - August 9 at 9:00 AM
	FTC Sends Warning To Online Sources Capitalizing Off Zika Fear With 'Protective' Products (NASDAQ:LMNX) feeds.benzinga.com - August 8 at 11:51 AM
	BRIEF-Luminex receives FDA emergency use authorization (NASDAQ:LMNX) feeds.reuters.com - August 8 at 9:24 AM
	LUMINEX CORP Financials (NASDAQ:LMNX) finance.yahoo.com - August 4 at 6:18 PM
	Luminex (LMNX) Gets FDA Nod for Assays; Q2 Earnings Beat (NASDAQ:LMNX) finance.yahoo.com - August 3 at 6:17 PM
	Luminex Corporation Receives FDA Clearance for New Molecular Test for Identification and Differentiation of Influenza A/B and Respiratory Syncytial Virus (NASDAQ:LMNX) finance.yahoo.com - August 3 at 9:12 AM
	Luminex Corporation Reports Second Quarter 2016 Results (NASDAQ:LMNX) www.publicnow.com - August 3 at 9:12 AM
	Edited Transcript of LMNX earnings conference call or presentation 29-Jul-16 12:30pm GMT (NASDAQ:LMNX) finance.yahoo.com - July 29 at 5:22 PM
	LUMINEX CORP Files SEC form 10-Q, Quarterly Report (NASDAQ:LMNX) biz.yahoo.com - July 29 at 10:28 AM
	Luminex : posts 2Q profit (NASDAQ:LMNX) www.4-traders.com - July 29 at 8:56 AM
	Luminex Corp Earnings Call scheduled for 8:30 am ET today (NASDAQ:LMNX) biz.yahoo.com - July 29 at 8:30 AM
	Luminex posts 2Q profit (NASDAQ:LMNX) sg.finance.yahoo.com - July 28 at 6:32 PM
	Luminex : Second Quarter Earnings Release Scheduled for July 28; Revision to Conference Call Date/Time (NASDAQ:LMNX) www.4-traders.com - July 28 at 6:08 PM
	LUMINEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (NASDAQ:LMNX) biz.yahoo.com - July 28 at 4:31 PM
	Q2 2016 Luminex Corp Earnings Release - After Market Close (NASDAQ:LMNX) biz.yahoo.com - July 28 at 7:07 AM
	Stock is unchanged at $22.12 (LMNX) Luminex Corporation Second Quarter… (NASDAQ:LMNX) www.fidaily.com - July 20 at 10:30 PM
	8:33 am Luminex alters 2Q16 conference call date/time to July 29 at 8:30 am ET from July 28 at 4:30 pm ET (NASDAQ:LMNX) finance.yahoo.com - July 20 at 8:33 AM
	Luminex Corporation Second Quarter Earnings Release Scheduled for July 28; Revision to Conference Call Date/Time (NASDAQ:LMNX) finance.yahoo.com - July 20 at 8:30 AM
	Luminex Corporation (LMNX) is Trading Higher on Unusual Volume for July 12 (NASDAQ:LMNX) www.equities.com - July 14 at 9:33 AM
	Luminex Corporation Receives FDA Clearance and CE-IVD Mark for the ARIES M1 System (NASDAQ:LMNX) www.publicnow.com - July 8 at 8:41 AM
	Luminex Corporation Second Quarter Earnings Release Scheduled for July 28, 2016 (NASDAQ:LMNX) finance.yahoo.com - July 8 at 8:30 AM
	Luminex Gets FDA Approval And CE-IVD Mark For Its ARIES M1 System (NASDAQ:LMNX) finance.yahoo.com - July 6 at 7:57 AM
	Luminex Closes Nanosphere Buyout, Maintains FY16 View (NASDAQ:LMNX) finance.yahoo.com - July 4 at 10:07 AM
	Luminex : To Present At Cantor Fitzgerald's 2nd Annual Healthcare Conference (NASDAQ:LMNX) www.4-traders.com - July 2 at 8:49 AM
	Form SC TO-T/A NANOSPHERE INC Filed by: LUMINEX CORP (NASDAQ:LMNX) www.streetinsider.com - July 2 at 8:49 AM
	Luminex Corporation (LMNX) is Trading Higher on Unusual Volume for June 30 (NASDAQ:LMNX) www.equities.com - July 2 at 8:49 AM
	Luminex Corp. breached its 50 day moving average in a Bullish Manner : LMNX-US : July 1, 2016 (NASDAQ:LMNX) www.capitalcube.com - July 1 at 8:22 AM
	LUMINEX CORP Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibit (NASDAQ:LMNX) biz.yahoo.com - June 30 at 2:19 PM
	Luminex Corporation To Present At Cantor Fitzgerald's 2nd Annual Healthcare Conference (NASDAQ:LMNX) www.publicnow.com - June 30 at 9:21 AM
	Luminex Corporation Completes Acquisition of Nanosphere, Inc. (NASDAQ:LMNX) finance.yahoo.com - June 30 at 8:55 AM
	Luminex Corp. – Value Analysis (NASDAQ:LMNX) : June 21, 2016 (NASDAQ:LMNX) www.capitalcube.com - June 21 at 11:31 AM
	Luminex Corp. breached its 50 day moving average in a Bearish Manner : LMNX-US : June 20, 2016 (NASDAQ:LMNX) www.capitalcube.com - June 20 at 8:30 AM
	Increased Earnings Estimates Seen for Luminex (LMNX): Can It Move Higher? (NASDAQ:LMNX) finance.yahoo.com - June 2 at 8:47 AM

Social

Luminex Corp. (NASDAQ:LMNX) Chart for Thursday, September, 29, 2016